FREE US SHIPPING OVER $200 · A2LA-ACCREDITED HPLC VERIFIED

Stillwater BioLabs
Growth Hormone Research

CJC-1295 (with DAC)

$100

CJC-1295 with DAC (Drug Affinity Complex) modification, supplied as a lyophilized reference standard for extended-half-life GHRH-receptor research. Distinct from the no-DAC form in pharmacokinetic profile.

$100

1 vial × $100 each

Add 3+ to unlock
volume pricing

Size:
VisaMastercardAmerican Express

Pay with Visa, Mastercard, or AMEX · ACH bank transfer saves 5%

Free US shipping on orders over $200, with tracking provided.

Third-party tested

In-vitro research only — not for human use

About CJC-1295 (with DAC)

CJC-1295 with DAC is a synthetic 30-amino-acid GHRH analog covalently modified with a Drug Affinity Complex side chain that binds endogenous albumin in preclinical models, extending the molecule's serum half-life from minutes (the no-DAC form) to days. Supplied as a lyophilized reference standard for in-vitro GHRH-receptor binding assays, half-life characterization, and pharmacokinetic method development. Researchers use this compound for extended-pulse-frequency GH-axis studies and analytical chromatographic reference. Not for use in any living organism.

Product specifications for CJC-1295 (with DAC)
PropertyValue
Product NameCJC-1295 (with DAC)
FormLyophilized Powder
AppearanceWhite to off-white powder
Purity≥99%
CAS Number863288-34-0
Molecular Weight3647.27 g/mol
StorageStore at -20°C. Reconstituted: 2-8°C, use within 21 days.

Disclaimer: The information provided is for research reference only and does not constitute medical advice. Products are sold strictly for in-vitro research use.

Related Research

Preclinical research summaries from our research blog covering the mechanisms and pharmacology relevant to this compound.

Related Products

Frequently Bought Together

CJC-1295 (with DAC)

5mg

$100

GIP3

10mg

$100

CJC-1295 (no DAC)

5mg

$45

Bundle total

$245